Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated with MACE.
Guardado en:
Autores principales: | Imperiali Claudia E., Lopez-Delgado Juan C., Dastis-Arias Macarena, Sanchez-Navarro Lourdes |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e3a432088204ee2b2c3ea069b3113a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluación del papel de diversos biomarcadores en el desarrollo de eventos cardiovasculares adversos mayores en pacientes sometidos a cirugía cardíaca
por: Imperiali Claudia E., et al.
Publicado: (2020) -
Benefits of monitoring patients with mobile cardiac telemetry (MCT) compared with the Event or Holter monitors
por: Tsang JP, et al.
Publicado: (2013) -
A Deep Learning-Based Text Classification of Adverse Nursing Events
por: Wenjing Lu, et al.
Publicado: (2021) -
A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding
por: Glineur D, et al.
Publicado: (2018) -
Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device
por: Daoud GE, et al.
Publicado: (2016)